GH Research PLC (GHRS) Form 10-Q Quarterly Reports
GH Research PLC (GHRS) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: GHRS
CIK: 1855129
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: L2
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerAlisa Hayden
Audit LocationDublin, Ireland
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-09 | 2026-10-09 | 6-K | 0001140361-26-039191 | View SEC Doc Filr Page |
| 6-K | 2026-09-11 | 2026-09-11 | 6-K Filing | 0001140361-26-036273 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-08 | FORM 4 | 0001140361-26-036052 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001346824-26-000231 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000902664-26-003520 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | FORM 4 | 0001140361-26-032856 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | FORM 4 | 0001140361-26-032846 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | FORM 4 | 0001140361-26-032843 | View SEC Doc Filr Page |
| 6-K | 2026-08-06 | 2026-06-30 | 6-K | 0001140361-26-031506 | View SEC Doc Filr Page |
| 6-K | 2026-06-26 | 2026-06-26 | 6-K | 0001140361-26-026497 | View SEC Doc Filr Page |
| 6-K | 2026-06-04 | 2026-06-04 | 6-K | 0001140361-26-023952 | View SEC Doc Filr Page |
| 6-K | 2026-05-21 | 2026-05-21 | 6-K | 0001140361-26-022330 | View SEC Doc Filr Page |
| EFFECT | 2026-05-19 | — | EFFECT Filing | 9999999995-26-001711 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-18 | — | SCHEDULE 13G/A Filing | 0000902664-26-002560 | View SEC Doc Filr Page |
| CORRESP | 2026-05-15 | — | CORRESP Filing | 0001140361-26-021701 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000902664-26-002532 | View SEC Doc Filr Page |
| UPLOAD | 2026-05-15 | — | UPLOAD Filing | 0000000000-26-004994 | View SEC Doc Filr Page |
| 6-K | 2026-05-14 | 2026-05-14 | 6-K | 0001140361-26-021331 | View SEC Doc Filr Page |
| F-3 | 2026-05-14 | — | F-3 | 0001140361-26-021176 | View SEC Doc Filr Page |
| 424B5 | 2026-05-14 | — | 424B5 | 0001140361-26-021169 | View SEC Doc Filr Page |
| 6-K | 2026-05-14 | 2026-03-31 | 6-K | 0001140361-26-021153 | View SEC Doc Filr Page |
| 6-K | 2026-05-13 | 2026-05-13 | 6-K | 0001140361-26-021079 | View SEC Doc Filr Page |
| 6-K | 2026-05-13 | 2026-05-13 | 6-K | 0001140361-26-020932 | View SEC Doc Filr Page |
| 6-K | 2026-04-30 | 2026-04-30 | 6-K | 0001140361-26-018239 | View SEC Doc Filr Page |
| 424B5 | 2026-04-29 | — | 424B5 | 0001140361-26-017654 | View SEC Doc Filr Page |